XML 82 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statement of Shareholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Total
Beginning Balance at Dec. 31, 2017 $ 1 $ 25,253 $ (20,788) $ (637) $ 3,829
Beginning Balance (in shares) at Dec. 31, 2017 67,031,467        
Other comprehensive loss (income)       (529) (529)
Common stock issued, net of transaction costs of $1,906   11,647     11,647
Common stock issued, net of transaction costs of $1,906 (Shares) 22,017,295        
Warrants issued, net of transaction costs of $322   1,873     1,873
Agents' warrants issued   330     330
Interest paid by issuance of common shares   231     231
Interest paid by issuance of common shares (in shares) 307,069        
Conversion of convertible debentures   16     16
Conversion of convertible debentures (in shares) 17,036        
Warrants exercised   2,295     2,295
Warrants exercised (in shares) 4,044,606        
Options exercised   33     33
Options exercised (in shares) 60,000        
Stock-based compensation   370     370
Net loss for the year     (10,108)   (10,108)
Ending Balance at Dec. 31, 2018 $ 1 42,048 (30,896) (1,166) 9,987
Ending Balance (in shares) at Dec. 31, 2018 93,477,473        
Modified retrospective adjustment upon adoption of ASC 842     49   49
Other comprehensive loss (income)       330 330
Interest paid by issuance of common shares   233     233
Interest paid by issuance of common shares (in shares) 415,179        
Options exercised   21     21
Options exercised (in shares) 50,000        
Stock-based compensation   333     333
Net loss for the year     (10,660)   (10,660)
Ending Balance at Dec. 31, 2019 $ 1 $ 42,635 $ (41,507) $ (836) $ 293
Ending Balance (in shares) at Dec. 31, 2019 93,942,652